Related Experiment Video
Updated: Mar 28, 2026

08:45
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.7K
HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship
Heiko Bode1, Florence Bourquin2, Saranya Suriyanarayanan3
1Institute for Clinical Chemistry, University Hospital Zurich, Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
Human Molecular Genetics
|December 19, 2015
Summary
Hereditary sensory and autonomic neuropathy type 1 (HSAN1) is caused by mutations in serine palmitoyltransferase (SPT). These mutations lead to toxic lipid production, with distinct biochemical properties correlating to HSAN1 severity.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- Hereditary sensory and autonomic neuropathy type 1 (HSAN1) is a rare inherited peripheral neuropathy.
- It is caused by mutations in SPTLC1 and SPTLC2 subunits of serine palmitoyltransferase (SPT).
- Mutations cause a shift in substrate preference, leading to neurotoxic 1-deoxy-sphingolipids (1-deoxySL).
Purpose of the Study:
- To compare the enzymatic properties of HSAN1-associated SPTLC1 and SPTLC2 mutants.
- To correlate biochemical properties with clinical HSAN1 phenotypes.
- To investigate the structural basis of mutation-induced pathogenicity.
Main Methods:
- Enzymatic assays of 17 SPT mutants (11 SPTLC1, 6 SPTLC2) using uniform isotope labeling.
- Analysis of sphingoid base profiles in patient plasma.
- Principal component analysis and homology modeling of SPT structure.
Main Results:
- Eight SPT mutants showed increased 1-deoxySL synthesis.
- No mutants exhibited reduced canonical activity with L-serine.
- Three variants (SPTLC1p.S331F/Y, SPTLC2p.I505Y) showed increased canonical activity and C20 sphingoid base formation, correlating with severe HSAN1.
- Plasma sphingoid base profiles clustered mutations into three groups linked to distinct clinical outcomes (no, mild, severe HSAN1).
Conclusions:
- HSAN1-associated SPT mutations possess distinct biochemical properties.
- Plasma sphingoid base profiles can predict HSAN1 clinical symptoms.
- Structural analysis reveals distinct clustering of mild and severe mutation sites relative to the SPT active site.
Related Concept Videos
ATP Synthase: Mechanism
18.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.8K
ATP Synthase: Structure
17.4K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
17.4K
Allosteric Proteins-ATCase
6.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K

